Suvitie P

No ORCID on file · 14 papers in corpus
other 2025

Endometriosis is a common inflammatory estrogen-dependent gynecological disorder, associated with pelvic pain and reduced fertility in women. Several aspects of this disorder and its cellular and molecular etiology remain unresolved. We hav…

other 2025
BMC women's health ·doi:10.1186/s12905-025-03699-y

BACKGROUND: Sacral neuromodulation (SNM) is an established therapy in urology and gastroenterological surgery for treatment of overactive bladder symptoms, urge urinary incontinence or fecal incontinence. SNM has also been used with good re…

observational 2024
·doi:10.21203/rs.3.rs-4088264/v1

Abstract Background Sacral neuromodulation (SNM) is an established therapy in urology and gastroenterological surgery for treatment of overactive bladder symptoms, urge urinary incontinence or fecal incontinence. SNM has also been used wi…

observational 2024
·doi:10.21203/rs.3.rs-4177916/v1

Abstract Background: When peritoneal endometriosis is clinically suspected, empirical medical therapy should be the first-line treatment. Diagnostic and therapeutic laparoscopy may be offered after failed or unsuitable medical therapy in wo…

case-report 2022

Copyright (C) 2017 Maija Lavonius et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is …

other 2020
Scientific data ·doi:10.1038/s41597-020-00623-x

Endometriosis is a common inflammatory estrogen-dependent gynecological disorder, associated with pelvic pain and reduced fertility in women. Several aspects of this disorder and its cellular and molecular etiology remain unresolved. We hav…

review 2018
Duodecim; laaketieteellinen aikakauskirja

Dysmenorrhea affects quality of life, but is often inadequately treated in teenagers. The mainstay of treatment is NSAID, which must be started pre-emptively and in adequate dose. If NSAID provides insufficient pain relief, or when contrace…

other 2018
Human Reproduction ·doi:10.1093/humrep/dey026

STUDY QUESTION: What is the role of SFRP2 in endometriosis? SUMMARY ANSWER: SFRP2 acts as a canonical WNT/CTNNB1 signaling agonist in endometriosis, regulating endometriosis lesion growth and indicating endometriosis lesion borders togethe…

nonrandomized-trial 2017
Journal of Pediatric and Adolescent Gynecology ·doi:10.1016/j.jpag.2017.01.014

STUDY OBJECTIVE: To study the safety and efficacy of dienogest 2 mg in adolescents with suspected endometriosis. DESIGN: A 52-week, open-label, single-arm study. SETTING: In 21 study centers, in 6 European countries. PARTICIPANTS: Adoles…

case-report 2017
Case reports in neurological medicine ·doi:10.1155/2017/2197831

Excision of all endometriotic lesions is the method of choice in the treatment of severe endometriosis resistant to medical therapy. The infiltrating nature of the disease as well as extensive surgery may, however, cause chronic pain that c…

review 2016
Duodecim; laaketieteellinen aikakauskirja

In adenomyosis, endometrial glandular and stromal cells grow inside the myometrium, and form localized or diffusely expanding islets. Smooth muscle cells of the uterus surrounding the adenomyosis colonies become hypertrophic, which may lead…

observational 2014
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2014-1913

CONTEXT: Aberrant sex steroid signaling is suggested to promote endometriosis growth by several mechanisms, and the tissue concentrations of sex steroids are key determinants of the hormone action. However, their concentrations are only sup…

observational 2012
Gynecologic Oncology ·doi:10.1016/j.ygyno.2012.03.011

OBJECTIVE: Human epididymal secretory protein E4 (HE4) is a new promising tumor marker developed for the diagnostics and follow up of ovarian cancer. It has yet to become widely accepted in clinical practice, and its biological properties h…

other 2009
British journal of cancer ·doi:10.1038/sj.bjc.6605011

Human epididymal secretory protein E4 (HE4, also known as WAP four-disulphide core domain protein 2) is a new promising biomarker for ovarian cancer but its specificity against ovarian endometriotic cysts is only superficially known. We, th…